Net Cash Provided by (Used in) Operating Activities |
291M |
USD |
-46.4% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-62.1M |
USD |
-907% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-187M |
USD |
+6.58% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
120M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
72M |
shares |
+0.38% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
42.5M |
USD |
-87.9% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
356M |
USD |
-40.7% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
70M |
USD |
+7.19% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
1.66M |
USD |
-16.5% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
7M |
USD |
|
Q2 2025 |
Q2 2025 |
Payments to Acquire Property, Plant, and Equipment |
187M |
USD |
-15.2% |
Q1 2025 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
196M |
USD |
+11.1% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
357M |
USD |
+43.1% |
Q4 2024 |
FY 2024 |
Unrecognized Tax Benefits |
1.28M |
USD |
-58.5% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
487M |
USD |
+24.3% |
Q4 2024 |
FY 2024 |
Interest Expense |
287M |
USD |
+5.46% |
Q1 2024 |
Q1 2024 |